Cystic fibrosis: To ion transport and beyond

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 991-992

  Bush, A ^a   Davies, J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL SODIUM CHANNEL; MUCIN 5AC; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ALPHA; ROSIGLITAZONE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

CHLORIDE TRANSPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; EDITORIAL; HUMAN; ION TRANSPORT; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SODIUM TRANSPORT;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; EPITHELIAL SODIUM CHANNEL; HUMANS;

EID: 78349232052     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00056310     Document Type: Editorial

References (20)

1. Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981; 305: 1489-1495. (Pubitemid 12244203)
2. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10: 487-493.
3. Cantin AM, Hanrahan JW, Bilodeau G, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 2006; 173: 1139-1144. (Pubitemid 43726895)
4. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-1015. (Pubitemid 29019052)
5. Tarran R, Button B, Picher M, et al. Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections. J Biol Chem 2005; 280: 35751-35759. (Pubitemid 41532768)
6. Widdicombe JH. Yet another role for the cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol 2000; 22: 11-14. (Pubitemid 30342954)
7. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 2005; 39: 292-298. (Pubitemid 40416794)
8. Wang X, Venable J, LaPointe P, et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006; 127: 803-815. (Pubitemid 44716255)
9. Ranganathan S, Dezateux C, Bush A, et al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001; 358: 1964-1965. (Pubitemid 34072881)
10. Ranganathan S, Bush A, Dezateux C, et al. Relative ability of full and partial forced expiratory manoeuvres to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med 2002; 166: 1350-1357. (Pubitemid 35292701)
11. Ranganathan SC, Stocks J, Dezateux C, et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 928-933.
12. Kozlowska WJ, Bush A, Wade A, et al. Lung function from infancy to the preschool years following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 42-49.
13. Nielsen KG, Pressler T, Klug B, et al. Serial lung function and responsiveness in cystic fibrosis during early childhood. Am J Respir Crit Care Med 2004; 169: 1209-1216.
14. Hilliard TN, Regamey N, Shute J, et al. Airway remodelling in children with cystic fibrosis. Thorax 2007; 62: 1074-1080.
15. Sutcliffe AM, Knox AJ. Muscling into cystic fibrosis airways. Thorax 2005; 60: 181-182.
16. Hilliard TN, Zhu J, Farley R, et al. Nasal abnormalities in cystic fibrosis mice independent of infection and inflammation. Am J Respir Cell Mol Biol 2008; 39: 19-25.
17. Dif F, Wu Y-Z, Burgel P-R, et al. Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTRdeficient mice. Eur Respir J 2010; 36: 1120-1130.
18. Henke MO, Renner A, Huber RM, et al. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 2004; 31: 86-91.
19. Harmon GS, Dumlao DS, Ng DT, et al. Pharmacological correction of a defect in PPAR-γ signalling ameliorates disease severity in Cftr-deficient mice. Nat Med 2010; 16: 313-318.
20. Perez A, van Heeckeren AM, Nichols D, et al. Peroxisome proliferator-activated receptor-γ in cystic fibrosis lung epithelium. Am J Physiol Lung Cell Mol Physiol 2008; 295: L303-L318.